Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer
Prostate Cancer
Conditions: official terms
Prostatic Neoplasms
Conditions: Keywords
Raypilot dosimetry, CBCT (cone beam computed tomography)
Study Type
Study Phase
Study Design
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Name: CBCT Type: Other
Name: fiducial marker (kV imaging) Type: Other
Name: IGRT Associated With IMRT Type: Radiation
Overall Status
This study evaluates the dose received by the prostate with in vivo dosimetry when delivering image guided radiation therapy (IGRT) associated with intensity modulated radiation therapy (IMRT) for patients with localized prostate cancer using two repositioning techniques: fiduciary markers or soft tissues.
Detailed Description
10 participants will receive a cone beam computed tomography (CBCT) repositioning, while the other 10 will receive a kV imaging of fiducial marker repositioning. The principal objective is to evaluate and compare the dose received by the prostate using two repositioning techniques.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Male
Criteria: Inclusion Criteria:

- male > 18 years

- carcinoma of the prostate histologically confirmed

- OMS 0-1

- localized stage

- favorable, intermediate and unfavorable groups according to NCCN or D'Amico classification

- patients must have signed a written informed consent form

- patients must be affiliated to a Social Health Insurance.

Exclusion Criteria:

- metastasis

- indication for pelvic radiation

- anticoagulant therapy

- lateral or bilateral hip replacement

- patient receiving an adult protective services

- Patient unable to comply with the required medical follow-up for geographic, social or psychological reasons
Centre Georges-François Leclerc
Dijon, France
Status: Recruiting
Contact: Liping DONG, MD - 0033 3 80 73 75 00 - LDong@cgfl.fr
Start Date
December 2014
Centre Georges Francois Leclerc
Centre Georges Francois Leclerc
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page